Log in | Register

Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analyses

Christiane S. Hartog| Helga Skupin| Charles Natanson| Junfeng Sun| Konrad Reinhart
Systematic Review
Volume 38, Issue 8 / August , 2012

Pages 1258 - 1271

Abstract

Purpose

Hydroxyethyl starch (HES) is a synthetic colloid used widely for resuscitation despite the availability of safer, less costly fluids. Numerous HES reviews have been published that may have influenced clinicians’ practice. We have therefore examined the relationship between the methodological quality of published HES reviews, authors’ potential conflicts of interest (pCOI) and the recommendations made.

Methods

Systematic analysis of reviews on HES use.

Results

Between 1975 and 2010, 165 reviews were published containing recommendations for or against HES use. From the 1990s onwards, favorable reviews increased from two to eight per year and HES’s share of the artificial colloid market tripled from 20 to 60 %. Only 7 % (12/165) of these reviews of HES use contained meta-analyses; these 7 % had higher Overview Quality Assessment Questionnaire (OQAQ) scores [median (range) 6.5 (3–7)] than reviews without meta-analysis [2 (1–4); p < 0.001]. The rates of recommending against HES use are 83 % (10/12) in meta-analyses and 20 % (31/153) in reviews without meta-analysis (p < 0.0001). Fourteen authors published the majority (70/124) of positive reviews, and ten of these 14 had or have since developed a pCOI with various manufacturers of HES.

Conclusions

Low-quality HES reviews reached different conclusions than high-quality meta-analyses from independent entities, such as Cochrane Reviews. The majority of these low-quality positive HES reviews were written by a small group of authors, most of whom had or have since established ties to industry. The proliferation of positive HES reviews has been associated with increased utilization of an expensive therapy despite the lack of evidence for meaningful clinical benefit and increased risks. Clinicians need to be more informed that marketing efforts are potentially influencing scientific literature.

Keywords

References

  1. Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, Du B, McArthur C, Myburgh J, Investigators TS (2010) Resuscitation fluid use in critically ill adults: an international cross sectional study in 391 intensive care units. Critical Care (Lond) 14:R185
    • View reference on publisher's website
  2. Schortgen F, Deye N, Brochard L (2004) Preferred plasma volume expanders for critically ill patients: results of an international survey. Intensive Care Med 30:2222–2229
  3. The FLUIDS study investigators for the Scandinavian Critical Care Trials Group (2008) Preferences for colloid use in Scandinavian intensive care units. Acta Anaesthesiol Scand 52:750-758
  4. Basora M, Moral V, Llau JV, Silva S (2007) Perioperative colloid administration: a survey of Spanish anesthesiologists’ attitudes. Rev Esp Anestesiol Reanim 54:162–168
    • View reference on PubMed
  5. Liu FC, Liao CH, Chang YW, Liou JT, Day YJ (2009) Hydroxyethyl starch interferes with human blood ex vivo coagulation, platelet function and sedimentation. Acta Anaesthesiol Taiwan 47:71–78
    • View reference on PubMed
    • View reference on publisher's website
  6. Hartog CS, Brunkhorst FM, Bloos F, Bogatsch H, Engel C, Sengebusch K, Reinhart K, Ragaller M (2010) Practice of volume therapy in patients with severe sepsis: results from a nationwide sepsis prevalence study. Intensive Care Med 36:553–554
  7. Westphal M, James MF, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H (2009) Hydroxyethyl starches: different products—different effects. Anesthesiology 111:187–202
    • View reference on PubMed
    • View reference on publisher's website
  8. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139
    • View reference on PubMed
    • View reference on publisher's website
  9. Zarychanski R, Turgeon AF, Fergusson DA, Cook DJ, Hebert P, Bagshaw SM, Monsour D, McIntyre LA (2009) Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: systematic review and meta-analysis of randomized trials. Open Med 3:E196–E209
    • View reference on PubMed
  10. Dart AB, Mutter TC, Ruth CA, Taback SP (2010) Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database of Systematic Reviews (Online):CD007594
  11. Wilkes MM, Navickis RJ, Sibbald WJ (2001) Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg 72:527–533
    • View reference on PubMed
    • View reference on publisher's website
  12. Perel P, Roberts I (2009) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews (Online):CD000567
  13. Bunn F, Trivedi D, Ashraf S (2008) Colloid solutions for fluid resuscitation. Cochrane Database of Systematic Reviews (Online):CD001319
  14. Mishler JM (1984) Synthetic plasma volume expanders—their pharmacology, safety and clinical efficacy. Clin Haematol 13:75–92
    • View reference on PubMed
  15. Vincent JL (1991) Fluids for resuscitation. Br J Anaesth 67:185–193
    • View reference on PubMed
    • View reference on publisher's website
  16. Treib J, Baron JF, Grauer MT, Strauss RG (1999) An international view of hydroxyethyl starches. Intensive Care Med 25:258–268
  17. de Jonge E, Levi M (2001) Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 29:1261–1267
    • View reference on PubMed
    • View reference on publisher's website
  18. Kozek-Langenecker SA (2005) Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 103:654–660
    • View reference on PubMed
    • View reference on publisher's website
  19. Boldt J (2009) Modern rapidly degradable hydroxyethyl starches: current concepts. Anesth Analg 108:1574–1582
    • View reference on PubMed
    • View reference on publisher's website
  20. McAlister FA, Graham I, Karr GW, Laupacis A (1999) Evidence-based medicine and the practicing clinician. J Gen Intern Med 14:236–242
    • View reference on PubMed
    • View reference on publisher's website
  21. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 354:1896–1900
    • View reference on PubMed
    • View reference on publisher's website
  22. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Br Med J (Clinical Research edn) 339:b2700
    • View reference on publisher's website
  23. Guyatt GH, Haynes RB, Jaeschke RZ, Cook DJ, Green L, Naylor CD, Wilson MC, Richardson WS (2000) Users’ Guides to the Medical Literature: XXV. Evidence-based medicine: principles for applying the Users’ Guides to patient care. Evidence-based medicine working group. JAMA 284:1290–1296
    • View reference on PubMed
    • View reference on publisher's website
  24. Loke YK, Derry S (2003) Does anybody read “evidence-based” articles? BMC Med Res Methodol 3:14
    • View reference on PubMed
    • View reference on publisher's website
  25. Cook DJ, Mulrow CD, Haynes RB (1997) Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 126:376–380
    • View reference on PubMed
  26. Schmidt LM, Gotzsche PC (2005) Of mites and men: reference bias in narrative review articles: a systematic review. J Fam Pract 54:334–338
    • View reference on PubMed
  27. Oxman AD, Guyatt GH, Singer J, Goldsmith CH, Hutchison BG, Milner RA, Streiner DL (1991) Agreement among reviewers of review articles. J Clin Epidemiol 44:91–98
    • View reference on PubMed
    • View reference on publisher's website
  28. Shikowitz MJ (1991) Sudden sensorineural hearing loss. Med Clin N Am 75:1239–1250
    • View reference on PubMed
  29. Heilmann L, Siekmann U, Schmid-Schonbein H (1985) The rheologic properties of the blood during pregnancy. Dtsch Med Wochenschr 110:1705–1708
    • View reference on PubMed
    • View reference on publisher's website
  30. Laatikainen LT (1992) Management of retinal vein occlusion. Curr Opin Ophthalmol 3:372–378
    • View reference on PubMed
    • View reference on publisher's website
  31. Aboulghar MA, Mansour RT, Aboulghar MA, Mansour RT (2003) Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update 9:275–289
    • View reference on PubMed
    • View reference on publisher's website
  32. Forouzandeh B, Konicek F, Sheagren JN (1996) Large-volume paracentesis in the treatment of cirrhotic patients with refractory ascites. The role of postparacentesis plasma volume expansion. J Clin Gastroenterol 22:207–210
    • View reference on PubMed
    • View reference on publisher's website
  33. Berger W, Keller U, Berger W, Keller U (1992) Treatment of diabetic ketoacidosis and non-ketotic hyperosmolar diabetic coma. Baillieres Clin Endocrinol Metab 6:1–22
    • View reference on PubMed
    • View reference on publisher's website
  34. Leschke M, Klimek W, Jung F (2003) Rheological determinants of end-organ damage. Der Internist 44:853–863
    • View reference on PubMed
    • View reference on publisher's website
  35. Linde I (1993) Indications and contraindications of plasmapheresis and autologous blood donation. Beitr Infusionstherap (Contributions to infusion therapy) 29:158–162
  36. Nusbacher J, McCullough J, Huestis DW (1977) Granulocyte collection and processing. Prog Clin Biol Res 13:175–183
  37. Southard JH, Belzer FO (1995) Organ preservation. Annu Rev Med 46:235–247
    • View reference on PubMed
    • View reference on publisher's website
  38. Raju GM, Kochupillai V, Kumar L (1995) Storage of haemopoietic stem cells for autologous bone marrow transplantation. Natl Med J India 8:216–221
    • View reference on PubMed
  39. Kreimeier U, Christ F, Frey L, Habler O, Thiel M, Welte M, Zwissler B, Peter K (1997) Small-volume resuscitation for hypovolemic shock. Concept, experimental and clinical results. Der Anaesthesist 46:309–328
    • View reference on PubMed
    • View reference on publisher's website
  40. Delaney A, Bagshaw SM, Ferland A, Manns B, Laupland KB, Doig CJ (2005) A systematic evaluation of the quality of meta-analyses in the critical care literature. Critical Care (London, England) 9:R575–R582
    • View reference on publisher's website
  41. Choi PT, Halpern SH, Malik N, Jadad AR, Tramer MR, Walder B (2001) Examining the evidence in anesthesia literature: a critical appraisal of systematic reviews. Anesth Analg 92:700–709
    • View reference on PubMed
    • View reference on publisher's website
  42. Shea BJ, Hamel C, Wells GA, Bouter LM, Kristjansson E, Grimshaw J, Henry DA, Boers M (2009) AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol 62:1013–1020
    • View reference on PubMed
    • View reference on publisher's website
  43. Nolan J (1999) Fluid replacement. Br Med Bull 55:821–843
    • View reference on PubMed
    • View reference on publisher's website
  44. Artificial colloids. Market analysis. IMS Health (2009)
  45. Barron ME, Wilkes MM, Navickis RJ (2004) A systematic review of the comparative safety of colloids. Arch Surg 139:552–563
    • View reference on PubMed
    • View reference on publisher's website
  46. Thompson WL (1975) Rational use of albumin and plasma substitutes. Johns Hopkins Med J 136:220–225
    • View reference on PubMed
  47. Boldt J (2006) Volume therapy in cardiac surgery: are Americans different from Europeans? J Cardiothorac Vasc Anesth 20:98–105
    • View reference on PubMed
    • View reference on publisher's website
  48. Gosling P, Rittoo D, Manji M, Mahmood A, Vohra R (2001) Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet 358:581 author reply 582
    • View reference on PubMed
    • View reference on publisher's website
  49. Boldt J (2006) Do plasma substitutes have additional properties beyond correcting volume deficits? Shock (Augusta Ga) 25:103–116
    • View reference on publisher's website
  50. Zikria BA, King TC, Stanford J, Freeman HP (1989) A biophysical approach to capillary permeability. Surgery 105:625–631
    • View reference on PubMed
  51. Boldt J (2008) Saline versus balanced hydroxyethyl starch: does it matter? Curr Opin Anaesthesiol 21:679–683
    • View reference on PubMed
    • View reference on publisher's website
  52. Boldt J, Ince C (2010) The impact of fluid therapy on microcirculation and tissue oxygenation in hypovolemic patients: a review. Intensive Care Med 36:1299–1308
  53. Adams HA, Vogt PM (2009) Circulation therapy for severe burn injuries. Der Unfallchirurg 112:462–471
    • View reference on PubMed
    • View reference on publisher's website
  54. Powell-Tuck J, Gosling P, Lobo DN, Allison S, Carlson GL, Gore M, Lewington AJ, Pearse RM, Mythen MG, (2008) British consensus guidelines on intravenous fluid therapy for adult surgical patients (GIFTASUP). 2008. London: NHS National Library of Health. Available at: http://www.ics.ac.uk/downloads/2008112340_GIFTASUP%20FINAL_31-10-08.pdf doi
  55. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296–327
    • View reference on PubMed
    • View reference on publisher's website
  56. The American Thoracic Society Colloid Working Group (2004) Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. Am J Respir Crit Care Med 170:1247–1259
  57. Reinhart K, Brunkhorst FM, Bone HG, Bardutzky J, Dempfle CE, Forst H, Gastmeier P, Gerlach H, Grundling M, John S, Kern W, Kreymann G, Kruger W, Kujath P, Marggraf G, Martin J, Mayer K, Meier-Hellmann A, Oppert M, Putensen C, Quintel M, Ragaller M, Rossaint R, Seifert H, Spies C, Stuber F, Weiler N, Weimann A, Werdan K, Welte T (2010) Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI). Der Anaesthesist 59:347–370
    • View reference on PubMed
    • View reference on publisher's website
  58. Joannidis M, Druml W, Forni LG, Groeneveld AB, Honore P, Oudemans-van Straaten HM, Ronco C, Schetz MR, Woittiez AJ (2009) Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM. Intensive Care Med 36:392–411
  59. Greaves I, Porter KM, Revell MP (2002) Fluid resuscitation in pre-hospital trauma care: a consensus view. J R Coll Surg Edinb 47:451–457
    • View reference on PubMed
  60. Hardy JF, de Moerloose P, Samama CM (2006) Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth (J Canadien d’anesthesie) 53:S40–S58
    • View reference on publisher's website
  61. Human albumin expert group (2000) Indications for the use of human albumin solutions: an expert report. Schweiz Med Wochenschr 130:516–522
  62. Kruskall MS, Mintz PD, Bergin JJ, Johnston MF, Klein HG, Miller JD, Rutman R, Silberstein L (1988) Transfusion therapy in emergency medicine. Ann Emerg Med 17:327–335
    • View reference on PubMed
    • View reference on publisher's website
  63. Martel MJ, MacKinnon KJ, Arsenault MY, Bartellas E, Klein MC, Lane CA, Sprague AE, Wilson AK (2002) Hemorrhagic shock. J Obstet Gynaecol Can 24:504–520 quiz 521–504
    • View reference on PubMed
  64. Vermeulen LC Jr, Ratko TA, Erstad BL, Brecher ME, Matuszewski KA (1995) A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med 155:373–379
    • View reference on PubMed
    • View reference on publisher's website
  65. Asplund K (2009) Haemodilution for acute ischaemic stroke. Cochrane database of systematic reviews (Online):CD000103
  66. Himpe D (2003) Colloids versus crystalloids as priming solutions for cardiopulmonary bypass: a meta-analysis of prospective, randomised clinical trials. Acta Anaesthesiol Belg 54:207–215
    • View reference on PubMed
  67. Cyna AM, Andrew M, Emmett RS, Middleton P, Simmons SW (2009) Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane database of systematic reviews (Online):CD002251
  68. Toomtong P, Suksompong S (2010) Intravenous fluids for abdominal aortic surgery. Cochrane database of systematic reviews (Online):CD000991
  69. Dretzke J, Sandercock J, Bayliss S, Burls A (2004) Clinical effectiveness and cost-effectiveness of prehospital intravenous fluids in trauma patients. Health technology assessment (Winchester, England) 8(23):1–103
  70. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P (2008) The effects of hydroxyethyl starch 130/0.4 (6 %) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 107:382–390
    • View reference on PubMed
    • View reference on publisher's website
  71. Wang AT, McCoy CP, Murad MH, Montori VM (2010) Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review. Br Med J (Clinical Research edn) 340:c1344
    • View reference on publisher's website
  72. Jorgensen AW, Hilden J, Gotzsche PC (2006) Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. Br Med J (Clinical Research edn) 333:782
    • View reference on publisher's website
  73. Barnes DE, Bero LA (1998) Why review articles on the health effects of passive smoking reach different conclusions. JAMA 279:1566–1570
    • View reference on PubMed
    • View reference on publisher's website
  74. Stelfox HT, Chua G, O’Rourke K, Detsky AS (1998) Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 338:101–106
    • View reference on PubMed
    • View reference on publisher's website
  75. Fugh-Berman A, McDonald CP, Bell AM, Bethards EC, Scialli AR (2011) Promotional tone in reviews of menopausal hormone therapy after the women’s health initiative: an analysis of published articles. PLoS Med 8:e1000425
    • View reference on PubMed
    • View reference on publisher's website
  76. Shafer SL (2010) Notice of retraction. Anesth Analg 111:1567
    • View reference on PubMed
    • View reference on publisher's website
  77. Editors in-Chief (2011) Editor-in Chief statement regarding published clinical trials conducted without IRB approval by Joachim Boldt. Available at: http://journals.lww.com/ejanaesthesiology/Documents/EIC%20Joint%20Statement%20on%20Retractions%2012Mar2011.pdf. Accessed 12 Mar 2011
  78. Angell M (2000) Is academic medicine for sale? N Engl J Med 342:1516–1518
    • View reference on PubMed
    • View reference on publisher's website
  79. Groeneveld AB, Navickis RJ, Wilkes MM (2011) Update on the comparative safety of colloids: a systematic review of clinical studies. Ann Surg 253:470–483
    • View reference on PubMed
    • View reference on publisher's website
  80. Hartog CS, Kohl M, Reinhart K (2011) A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 112:635–645
    • View reference on PubMed
    • View reference on publisher's website
  81. Carey TS, Williams JW Jr, Oldham JM, Goodman F, Ranney LM, Whitener L, Morgan LC, Melvin CL (2008) Gabapentin in the treatment of mental illness: the echo chamber of the case series. J Psychiatr Pract 14[Suppl 1]:15–27
    • View reference on PubMed
    • View reference on publisher's website
  82. Murphy GS, Greenberg SB (2010) The new-generation hydroxyethyl starch solutions: the Holy Grail of fluid therapy or just another starch? J Cardiothorac Vasc Anesth 24:389–393
    • View reference on PubMed
    • View reference on publisher's website
  83. Landefeld CS, Steinman MA (2009) The Neurontin legacy–marketing through misinformation and manipulation. N Engl J Med 360:103–106
    • View reference on PubMed
    • View reference on publisher's website
  84. Prayle AP, Hurley MN, Smyth AR (2012) Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study. Br Med J (Clinical Research edn) 344:d7373
    • View reference on publisher's website
  85. National Health Service (2008) Colloids versus crystalloids for fluid resuscitation in critically ill patients. NHS evidence: quality, innovation, productivity and prevention (QIPP). Available online at: https://www.evidence.nhs.uk/qipp
  86. Schochl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C (2010) Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care (Lond) 14:R55
    • View reference on publisher's website
  87. Woessner R, Grauer MT, Dieterich HJ, Bepperling F, Baus D, Kahles T, Georgi S, Bianchi O, Morgenthaler M, Treib J (2003) Influence of a long-term, high-dose volume therapy with 6 % hydroxyethyl starch 130/0.4 or crystalloid solution on hemodynamics, rheology and hemostasis in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study. Pathophysiol Haemost Thromb 33:121–126
    • View reference on PubMed
    • View reference on publisher's website
  88. Dieterich HJ, Weissmuller T, Rosenberger P, Eltzschig HK (2006) Effect of hydroxyethyl starch on vascular leak syndrome and neutrophil accumulation during hypoxia. Crit Care Med 34:1775–1782
    • View reference on PubMed
    • View reference on publisher's website
  89. James MF (2008) The role of tetrastarches for volume replacement in the perioperative setting. Curr Opin Anaesthesiol 21:674–678
    • View reference on PubMed
    • View reference on publisher's website
  90. Vincent JL (2006) Resuscitation using albumin in critically ill patients: research in patients at high risk of complications is now needed. Br Med J (Clinical Research edn) 333:1029–1030
    • View reference on publisher's website
  91. Jungheinrich C, Scharpf R, Wargenau M, Bepperling F, Baron JF (2002) The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6 %, 500 mL) in mild-to-severe renal impairment. Anesth Analg 95:544–551
    • View reference on PubMed
  92. Ertmer C, Kampmeier TG, Rehberg S, Morelli A, Kohler G, Lange M, Bollen Pinto B, Hohn C, Hahnenkamp K, Van Aken H, Westphal M (2011) Effects of balanced crystalloid vs. 0.9 % saline-based vs. balanced 6 % tetrastarch infusion on renal function and tubular integrity in ovine endotoxemic shock*. Crit Care Med 39:783–792

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement